1
|
Bouteille C, Pere M, Chelghaf I, Rigaud J, Madec FX, Perrouin-Verbe MA, Loubersac T. Mini-percutaneous nephrolithotomy: Is smaller better for kidney stones in patients with neurogenic bladder? Fr J Urol 2024; 34:102522. [PMID: 37758606 DOI: 10.1016/j.purol.2023.09.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/01/2023] [Revised: 09/02/2023] [Accepted: 09/08/2023] [Indexed: 09/29/2023]
Abstract
INTRODUCTION Patients with neurologic bladder are at an increased risk for urolithiasis, and currently, data on mini-percutaneous nephrolithotomy in this population are limited. Our objective was to compare mini (15F)-percutaneous nephrolithotomy, standard (24F)-PCNL and flexible ureteroscopy in terms of efficacy and safety in treatment of kidney stones in patients with neurogenic lower urinary tract dysfunction (NLUTD). METHODS We conducted a retrospective monocentric study in our neuro-urological referral centre. All consecutive patients with NLUTD and a cumulative size of renal calculi greater than 15mm or 10mm in the lower calyx, who had extraction surgery between 2005 and 2020, were included. The primary endpoint was the one-session stone-free rate (SFR) at 3 months on a CT scan. The secondary endpoints were complication (Clavien-Dindo grading system), operative time, blood loss and length of hospital stay. RESULTS We performed 76 standard PCNL (sPCNL), 46 flexible ureteroscopy lithotripsy (fURL) and 25 miniaturized PCNL (mPCNL). The one-session SFR was 37.5% for the mPCNL group, 38.2% for the sPCNL group and 37% for the fURL group with no significant difference between the three procedures (P=0.99). Early complications, blood loss and transfusion rates were lower in the mPCNL group than in the sPCNL group (P=0.047) and comparable to fURL group. The final SFRs after a second intervention for mPCNL, sPCNL and fURL were 48%, 61.8% and 63%, respectively (P=0.67). CONCLUSION The efficacy of mPCNL in patients with NLUTD was not different from other techniques, but a significantly lower rate of complications than sPCNL was observed. LEVEL OF PROOF 3.
Collapse
Affiliation(s)
- C Bouteille
- Department of Urology, Nantes University Hospital, Nantes, France; 1, place Alexis-Ricordeau, 44000 Nantes, France.
| | - M Pere
- Direction de la recherche, plateforme de méthodologie et biostatistique, Nantes Hospital, Nantes, France
| | - I Chelghaf
- Department of Urology, Nantes University Hospital, Nantes, France
| | - J Rigaud
- Department of Urology, Nantes University Hospital, Nantes, France
| | - F X Madec
- Department of Urology, Foch Hospital, Suresnes, Paris, France
| | | | - T Loubersac
- Pediatric Urology Department, Nantes University Hospital, Nantes, France
| |
Collapse
|
2
|
Le Roy C, Lefèvre C, Lepoittevin L, Reiss B, Le Fort M, Rigaud J, Perrouin-Verbe B, Perrouin-Verbe MA. Switching from onabotulinum toxin A to abobotulinum toxin A for treating detrusor overactivity in spinal cord injured patient, does it really work? Prog Urol 2023; 33:503-508. [PMID: 37550178 DOI: 10.1016/j.purol.2023.07.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/28/2023] [Accepted: 07/10/2023] [Indexed: 08/09/2023]
Abstract
AIM To assess the efficacy of switching to Abobotulinumtoxin A (ATA) intradetrusor injections (IDI) after failure of Onabotulinumtoxin A (OTA) IDI for the treatment of neurogenic detrusor overactivity in patients with spinal cord injury (SCI). MATERIALS AND METHODS A single-centre retrospective chart review study. All SCI patients who started OTA IDI after 2011 and had an ATA IDI switch were included. The primary outcome was the clinical and urodynamic efficacy of the switch to ATA IIDs at the last follow-up. Secondary outcomes were initial efficacy, duration of ATA treatment, and patient outcome including the occurrence of augmentation enterocystoplasty at last follow-up. RESULTS Sixty-two patients were included. Eighteen patients (28.9%) were initially responders to ATA IDI. Nine patients (14.5%) remained responders at last follow-up after a median of 17 months (AE 8.8-29). Thirty-two patients (51.6%) had had or were awaiting augmentation enterocystoplasty with a follow-up time of 18.5 months (IQR 8-27). Eleven patients (17.7%) were on ATA IDI with low efficacy. Seven patients (11.3%) were switched back to OTA and 3 patients (4.8%) changed their voiding pattern. CONCLUSION Switching from OTA to ATA toxin for IDI in the treatment of detrusor overactivity after spinal cord injury have long-term efficacy for a limited number of patients but may delay the need for surgery. LEVEL OF EVIDENCE: 4
Collapse
Affiliation(s)
- C Le Roy
- Department of Physical Medicine and Rehabilitation, University Hospital of Nantes, Nantes, France.
| | - C Lefèvre
- Department of Physical Medicine and Rehabilitation, University Hospital of Nantes, Nantes, France
| | - L Lepoittevin
- Department of Physical Medicine and Rehabilitation, University Hospital of Nantes, Nantes, France
| | - B Reiss
- Department of Physical Medicine and Rehabilitation, University Hospital of Nantes, Nantes, France
| | - M Le Fort
- Department of Physical Medicine and Rehabilitation, University Hospital of Nantes, Nantes, France
| | - J Rigaud
- Department of Urology, University Hospital of Nantes, Nantes, France
| | - B Perrouin-Verbe
- Department of Physical Medicine and Rehabilitation, University Hospital of Nantes, Nantes, France
| | | |
Collapse
|
3
|
Mesnard B, de Vergie S, Chelghaf I, Bouchot O, Perrouin Verbe MA, Karam G, Branchereau J, Rigaud J. Robot-assisted radical nephroureterectomy for upper tract urothelial carcinoma: Peri and postoperative outcomes. Actas Urol Esp 2023; 47:441-449. [PMID: 36966898 DOI: 10.1016/j.acuroe.2023.03.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/19/2023] [Revised: 02/12/2023] [Accepted: 02/15/2023] [Indexed: 03/29/2023]
Abstract
INTRODUCTION The treatment of urothelial tumours of the upper urinary tract at high risk of specific mortality is based on radical nephroureterectomy (RNU). Robotic-assisted laparoscopic radical nephroureterectomy (RARNU) is still under investigation to definitively establish the safety of this procedure in the management of urothelial tumours of the upper urinary tract. The primary objective is to evaluate the intra- and postoperative safety of RARNU and, subsequently, to evaluate the medium-term oncological results. METHODS Our study is a retrospective, mono-centric study with a collection of RARNUs conducted between 1st January 2015 and 1st October 2021. The RARNUs were performed with the assistance of the Da Vinci Si® robot, then from 2017 the Da Vinci Xi® robot. Whenever possible, the entire procedure was carried out without re-docking. RESULTS Between 1st January 2015 and 1st October 2021, 29 RARNUs were carried out at our centre. Complete surgery without re-docking was possible in 80% of cases with the Da Vinci Xi® robot. One patient required conversion to open surgery due to difficult dissection. 50% of tumours were classified as T3 or T4. The 30-day complication rate was 31%. The median length of hospitalisation was 5 days. The disease-free survival at the mean survival time (27.5 months) was of 75.2%. One patient had a recurrence in the nephrectomy compartment and no patient had a peritoneal or trocar orifice recurrence. CONCLUSION Performing RARNU for the management of tumours of the upper urinary tract appears to meet the criteria of surgical safety and those of oncological safety.
Collapse
Affiliation(s)
- B Mesnard
- Department of Urology and Transplantation Surgery, Nantes University Hospital, Nantes, France.
| | - S de Vergie
- Department of Urology and Transplantation Surgery, Nantes University Hospital, Nantes, France
| | - I Chelghaf
- Department of Urology and Transplantation Surgery, Nantes University Hospital, Nantes, France
| | - O Bouchot
- Department of Urology and Transplantation Surgery, Nantes University Hospital, Nantes, France
| | - M A Perrouin Verbe
- Department of Urology and Transplantation Surgery, Nantes University Hospital, Nantes, France
| | - G Karam
- Department of Urology and Transplantation Surgery, Nantes University Hospital, Nantes, France
| | - J Branchereau
- Department of Urology and Transplantation Surgery, Nantes University Hospital, Nantes, France
| | - J Rigaud
- Department of Urology and Transplantation Surgery, Nantes University Hospital, Nantes, France
| |
Collapse
|
4
|
Chapelle C, Broudeur L, Bessard A, Durand T, Le Berre - Scoul C, Rigaud J, Baron M, Neunlist M, Perrouin-Verbe MA. Urothelial remodeling after spinal cord injury. Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)00884-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
5
|
Mesnard B, Lecoq J, De Vergie S, Perrouin Verbe MA, Chelghaf I, Karam G, Rigaud J, Descazeaud A, Robert G, Branchereau J. [Prostatic hyperplasia: Evaluation of practices in general practice, dissemination, and impact of recommendations]. Prog Urol 2023; 33:58-65. [PMID: 35842333 DOI: 10.1016/j.purol.2022.06.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/04/2022] [Revised: 05/11/2022] [Accepted: 06/13/2022] [Indexed: 02/01/2023]
Abstract
INTRODUCTION In 2015, the French Association of Urology, by the male lower urinary tract symptoms Committee, published a practices guideline for the management of prostatic hyperplasia in general practice. Five years after the publication of these recommendation, our objective is to assess their dissemination and their impact in general practice. MATERIAL A specially designed questionnaire was distributed online via the departmental councils of the order and to all regional unions of liberal doctors. The distribution to general practitioners was at the discretion of each organisation depending on local policies. RESULTS Two hundred and eighty responses were collected. Fifty-five percent of the population was female. 83 % of the general practitioners did not report having knowledge of the practice guideline. 77 % of doctors stated that they had not received training or information on prostatic hyperplasia in the past 5 years. Among the notable results, 51 % of general practitioners declared performing a digital rectal examination. 44 % prescribed an endorectal ultrasound. Only 7 % of doctors were aware of the existence of minimally invasive surgical techniques. CONCLUSION The practices guideline for the management of prostatic hyperplasia in general practice proposed in 2015 by the male lower urinary tract symptoms Committee seems to be little known by general practitioners. Dissemination of these recommendations solely through publication in Progrès en Urologie seems ill-suited to consideration by general practitioners, and it seems necessary to consider other modes of dissemination. LEVEL OF EVIDENCE 4, grade C.
Collapse
Affiliation(s)
- B Mesnard
- Department of Urology, Hôtel-Dieu Hospital, University of Nantes, Nantes, France
| | - J Lecoq
- Department of Urology, Hôtel-Dieu Hospital, University of Nantes, Nantes, France
| | - S De Vergie
- Department of Urology, Hôtel-Dieu Hospital, University of Nantes, Nantes, France
| | - M A Perrouin Verbe
- Department of Urology, Hôtel-Dieu Hospital, University of Nantes, Nantes, France
| | - I Chelghaf
- Department of Urology, Hôtel-Dieu Hospital, University of Nantes, Nantes, France
| | - G Karam
- Department of Urology, Hôtel-Dieu Hospital, University of Nantes, Nantes, France
| | - J Rigaud
- Department of Urology, Hôtel-Dieu Hospital, University of Nantes, Nantes, France
| | - A Descazeaud
- Department of Urology, University Hospital of Limoges, Limoges, France
| | - G Robert
- Department of Urology, Bordeaux Pellegrin University Hospital, University of Bordeaux, Bordeaux, France
| | - J Branchereau
- Department of Urology, Hôtel-Dieu Hospital, University of Nantes, Nantes, France.
| |
Collapse
|
6
|
Broudeur L, Loubersac T, Le Normand L, Karam G, Branchereau J, Rigaud J, Perrouin Verbe M. Robot-assisted laparoscopic artificial urinary sphincter implantation in women with posterior approach and intraoperative cystoscopic monitoring. Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)00929-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
7
|
Ochoa Vargas C, Broudeur L, Le Normand L, Karam G, Rigaud J, Perrouin-Verbe M. Robot-assisted female artificial urinary sphincter (AUS) implantation by posterior approach with endoscopy monitoring. Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)01444-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
8
|
Minard G, Prescornita R, Tralongo F, Kaisari E, Lacoste M, Rigaud J, Brézin A, Zini P, Chauveau Jouve P. Maladie de Vogt-Koyanagi-Harada après vaccination contre le COVID. Rev Med Interne 2022. [DOI: 10.1016/j.revmed.2022.10.270] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
|
9
|
Haberstich M, Pignot G, Rigaud J, Cancel M, Maillet D, Oudard S, Pouessel D, Serrate C, Campedel L, Dumont C, Borchiellini D, Barthelemy P, Boughalem E, Colomba E, Huillard O, Boyle H, Lefort F, Constans Schlurmann F, Audenet F, Thibault C. 1762P MERINOS: Metastatic non muscle invasive urothelial carcinoma - An observational study. Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.07.1840] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022] Open
|
10
|
Chelghaf I, Glemain P, Madec F, Loubersac T, de Vergie S, Branchereau J, Rigaud J, Perrouin-Verbe B, Lefort M, Perrouin-Verbe M. Néphrolithotomie percutanée chez les patients neurologiques : efficacité et morbidité à long terme. Prog Urol 2022; 32:442-450. [DOI: 10.1016/j.purol.2021.12.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/10/2021] [Revised: 11/05/2021] [Accepted: 12/14/2021] [Indexed: 10/18/2022]
|
11
|
Stessy K, Robin H, Bigot P, Baboudjian M, Françot M, De Vergie S, Rigaud J, Chapuis M, Brureau L, Jousseaume C, Karray O, Kosseifi F, Borojeni S, Lechevallier E, Bernardeau S, Bruyère F, Gondran-Tellier B, Vallée M. Epidemiology of asymptomatic bacteriuria prior urological surgery: preliminary results of the retrospective and multicenter TOCUS study. Eur Urol 2022. [DOI: 10.1016/s0302-2838(22)00121-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
12
|
Saar M, Fizazi K, Shore N, Smith M, Damber JE, Semenov A, Ribal Caparrós M, Birtle A, Rigaud J, Ortiz J, Schmall A, Srinivasan S, Verholen F. Effects of prior local therapy by radical prostatectomy or radiotherapy on the efficacy and safety of darolutamide in patients with nonmetastatic castration-resistant prostate cancer from aramis. Eur Urol 2022. [DOI: 10.1016/s0302-2838(22)01045-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
13
|
Brureau L, Chapuis M, Robin H, Bigot P, Baboudjian M, Françot M, De Vergie S, Rigaud J, Jousseaume C, Karray O, Kosseifi F, Borojeni S, Lechevallier E, Bernardeau S, Gondran-Tellier B, Bruyère F, Kutchukian S, Vallée M. Risk factors of infectious complications after benign prostatic hyperplasia surgery: Preliminary results from the retrospective and multicenter TOCUS cohort. Eur Urol 2022. [DOI: 10.1016/s0302-2838(22)00200-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
14
|
Stessy K, Robin H, Bigot P, Baboudjian M, Françot M, De Vergie S, Rigaud J, Chapuis M, Brureau L, Jousseaume C, Karray O, Kosseifi F, Borojeni S, Lechevallier E, Bernardeau S, Bruyère F, Gondran-Tellier B, Vallée M. Risk factors for postoperative infections after urological surgery: Preliminary results from the national and multicenter TOCUS study. Eur Urol 2022. [DOI: 10.1016/s0302-2838(22)00202-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
15
|
Branchereau J, Ogbemudia AE, Bas-Bernardet SL, Prudhomme T, Rigaud J, Karam G, Blancho G, Mesnard B. Novel Organ Perfusion and Preservation Strategies in Controlled Donation After Circulatory Death in Pancreas and Kidney Transplantation. Transplant Proc 2021; 54:77-79. [PMID: 34879976 DOI: 10.1016/j.transproceed.2021.09.059] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/23/2021] [Revised: 09/13/2021] [Accepted: 09/28/2021] [Indexed: 11/18/2022]
Abstract
BACKGROUND Kidney and pancreatic transplants from controlled donation after circulatory death donors are vulnerable to ischemia-reperfusion injuries. In this context of transplant shortage, there is a need to optimize the function of these transplants and to develop novel perfusion and preservation strategies in controlled donation after circulatory death in kidney and pancreatic transplants. IN SITU PERFUSION AND PRESERVATION STRATEGIES In situ regional normothermic perfusion improves the outcome of kidney transplants from controlled donation after circulatory death and provides equivalent results for the kidney from brain-dead donors. In situ regional normothermic perfusion is under investigation for pancreatic transplants. EX SITU PERFUSION AND PRESERVATION STRATEGIES Perfusion on hypothermic machine perfusion is highly recommended for the kidney from controlled donation after cardiac death. Hypothermic oxygenated perfusion machine decreases the rate of graft rejection and graft failure in kidney transplantation. Ex situ normothermic perfusion is an easy way to assess renal function. In the future, kidney transplants could benefit from drug therapy during ex situ normothermic perfusion. In pancreas transplantation, hypothermic machine perfusion and ex situ normothermic perfusion present encouraging results in preclinical studies.
Collapse
Affiliation(s)
- J Branchereau
- Department of Urology and Transplantation Surgery, Nantes, France; Nuffield Department of Surgical Science, Oxford, United Kingdom; Centre de Recherche en Transplantation et Immunologie (ou CRTI), Inserm, Nantes University, Nantes, France.
| | - A E Ogbemudia
- Nuffield Department of Surgical Science, Oxford, United Kingdom
| | - S Le Bas-Bernardet
- Centre de Recherche en Transplantation et Immunologie (ou CRTI), Inserm, Nantes University, Nantes, France
| | - T Prudhomme
- Centre de Recherche en Transplantation et Immunologie (ou CRTI), Inserm, Nantes University, Nantes, France
| | - J Rigaud
- Department of Urology and Transplantation Surgery, Nantes, France
| | - G Karam
- Department of Urology and Transplantation Surgery, Nantes, France; Centre de Recherche en Transplantation et Immunologie (ou CRTI), Inserm, Nantes University, Nantes, France
| | - G Blancho
- Centre de Recherche en Transplantation et Immunologie (ou CRTI), Inserm, Nantes University, Nantes, France
| | - B Mesnard
- Department of Urology and Transplantation Surgery, Nantes, France; Centre de Recherche en Transplantation et Immunologie (ou CRTI), Inserm, Nantes University, Nantes, France
| |
Collapse
|
16
|
Mesnard B, Cantarovich D, Martin-Lefevre L, Rigaud J, Blancho G, Karam G, Badet L, Antoine C, Branchereau J. First French combined kidney/pancreas transplantation from controlled donation after circulatory arrest (Maastricht III). Prog Urol 2021; 32:1-2. [PMID: 34772617 DOI: 10.1016/j.purol.2021.10.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/24/2021] [Accepted: 10/09/2021] [Indexed: 10/19/2022]
Affiliation(s)
- B Mesnard
- Clinique urologique, hôpital Hôtel-Dieu, CHU de Nantes, Nantes, France; Centre de Recherche en Transplantation et Immunologie UMR1064, INSERM, Université de Nantes, Nantes, France
| | - D Cantarovich
- Centre de Recherche en Transplantation et Immunologie UMR1064, INSERM, Université de Nantes, Nantes, France
| | | | - J Rigaud
- Clinique urologique, hôpital Hôtel-Dieu, CHU de Nantes, Nantes, France
| | - G Blancho
- Centre de Recherche en Transplantation et Immunologie UMR1064, INSERM, Université de Nantes, Nantes, France
| | - G Karam
- Clinique urologique, hôpital Hôtel-Dieu, CHU de Nantes, Nantes, France
| | - L Badet
- Hospices civils de Lyon, hôpital Edouard-Herriot, Lyon, France
| | - C Antoine
- Direction générale médicale et scientifique, agence de la biomédecine (ABM), Saint-Denis, France
| | - J Branchereau
- Clinique urologique, hôpital Hôtel-Dieu, CHU de Nantes, Nantes, France; Centre de Recherche en Transplantation et Immunologie UMR1064, INSERM, Université de Nantes, Nantes, France.
| |
Collapse
|
17
|
Lecoq J, Mesnard B, De Vergie S, Chelghaf I, Bouchot O, Perrouin Verbe M, Karam G, Rigaud J, Branchereau J. Évaluation des pratiques en médecine générale, diffusion et impact des recommandations du comité des troubles mictionnels de l’homme : l’hypertrophie bénigne de prostate. une enquête nationale. Prog Urol 2021. [DOI: 10.1016/j.purol.2021.08.069] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
18
|
Bouteille C, Chelghaf I, Glémain P, Rigaud J, Perrouin-verbe B, Lefort M, Kieny P, Perrouin-Verbe M, Loubersac T. Résultats d’une étude comparative de la mini-néphrolithotomie percutanée, néphrolithotomie percutanée et de l’urétérorénoscopie souple dans la prise en charge des calculs rénaux de plus de 15 mm chez les patients porteurs de vessie neurologique. Prog Urol 2021. [DOI: 10.1016/j.purol.2021.08.196] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
19
|
Robin H, Kutchukian S, Bigot P, Françot M, Devergie S, Rigaud J, Chapuis M, Brureau L, Kosseifi F, Borojeni S, Badoudjian M, Lechevallier E, Gondran-tellier B, Vallée M. Tocus : la durée de traitement antibiotique d’une colonisation urinaire préopératoire en chirurgie urologique influence-t-elle la survenue de complications infectieuses postopératoires ? Prog Urol 2021. [DOI: 10.1016/j.purol.2021.08.169] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
20
|
Chapuis M, Kutchukian S, Gondran-tellier B, Robin H, Bigot P, Francot M, De vergie S, Rigaud J, Kosseifi F, Borojeni S, Baboudjian M, Lechevallier E, Vallée M, Brureau L. Évaluation des facteurs de risque infectieux de la chirurgie de l’hypertrophie bénigne de la prostate : étude multicentrique Tocus. Prog Urol 2021. [DOI: 10.1016/j.purol.2021.08.170] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
21
|
Jeanne-julien A, Bouchot O, De Vergie S, Branchereau J, Rigaud J. Morbidité des curages ganglionnaires inguinaux et résultats oncologiques dans le cancer du pénis. Prog Urol 2021. [DOI: 10.1016/j.purol.2021.08.180] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
22
|
Quistrebert-Davanne V, Hardouin JB, Riant T, Ploteau S, Rigaud J, Levesque A. [Psychometric validation of Convergence criteria PP]. Prog Urol 2021; 31:1192-1200. [PMID: 34493442 DOI: 10.1016/j.purol.2021.07.011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/04/2021] [Revised: 06/29/2021] [Accepted: 07/16/2021] [Indexed: 10/20/2022]
Abstract
CONTEXT The PP Convergences criteria group together 10 of the most significant clinical criteria for sensitization in the context of chronic pelvic pain. They are the result of a consensus of experts and represent to date the only clinical evaluation guide to identify patients with pelvic perineal pain in whom a pelvic sensitization component can be evoked. OBJECTIVE This work concerns the psychometric validation of these criteria. The aim is to answer 3 questions: 1) is the instrument reliable (i.e., sensitive, specific and accurate)?; 2) can we define a screening score for pelvic-perineal pain by sensitization from the CPP criteria?; 3) can combinations of criteria be defined to predict pelvic-perineal sensitization from the CPP criteria? METHODOLOGY AND SUBJECTS In total, 308 patients with pelviperineal pain were recruited during their medical consultation. PROCEDURE Fifteen expert physicians were asked to judge the presence or absence of the 10 CPP criteria and to make a diagnosis of the presence or absence of pelviperineal sensitization in their patient. RESULTS ROC curve analysis indicated that a score of 5 was the closest to a perfect score with a sensitivity of 95% and a specificity of 87%. They also indicate that the CPP criteria have a very good sensitivity (97%) and specificity (91%) and present globally a good reproducibility on all the criteria (Kappa>0.6). Finally, the statistical analyses reveal that the most discriminating criterion for predicting sensitization is Q8 (pain persisting after sexual activity). CONCLUSION The CPP criteria represent a very good screening tool for pelvic sensitization. The score of 5 corresponds to the score at which the patient has sufficient clinical criteria to be classified as sensitized. LEVEL OF EVIDENCE 4.
Collapse
Affiliation(s)
- V Quistrebert-Davanne
- Centre fédératif de pelvipérinéologie et clinique urologique, CHU de Nantes, Nantes, France.
| | - J-B Hardouin
- Observatoire régional de la santé du Centre, Nantes, France
| | - T Riant
- CETD M Bensignor, hôpital privé du Confluent groupe VIVALTO, Nantes, France
| | - S Ploteau
- Centre fédératif de pelvipérinéologie et clinique urologique, CHU de Nantes, Nantes, France
| | - J Rigaud
- Centre fédératif de pelvipérinéologie et clinique urologique, CHU de Nantes, Nantes, France
| | - A Levesque
- Centre fédératif de pelvipérinéologie et clinique urologique, CHU de Nantes, Nantes, France
| |
Collapse
|
23
|
Mesnard B, Ogbemudia AE, Karam G, Dengu F, Hackim G, Rigaud J, Blancho G, Drouin S, Timsit MO, Branchereau J. What is the evidence for oxygenation during kidney preservation for transplantation in 2021? A scoping review. World J Urol 2021; 40:2141-2152. [PMID: 34432136 DOI: 10.1007/s00345-021-03757-8] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/31/2021] [Accepted: 06/07/2021] [Indexed: 11/25/2022] Open
Abstract
PURPOSE The main objective of static cold storage is to reduce cellular metabolic demands to extend the period of ischaemia prior to transplantation. Hypothermia does not halt metabolism and the absence of oxygen causes a cellular shift toward anaerobic respiratory pathways. There is emerging evidence that the introduction of oxygenation during organ preservation may help ameliorate the degree of ischaemia reperfusion injury and improve post-transplantation outcomes. This review aims to appraise and summarise all published literature that utilises oxygenation to improve kidney preservation for purposes of transplantation. METHODS We performed a scoping review of the literature using the bibliographic databases Embase and MEDLINE. The final date for searches was 20 March 2021. All research studies included were those that reported oxygen delivery during kidney preservation as well as providing a description of the oxygenation technique. RESULTS 17 human and 48 animal studies met the inclusion criteria. The oxygen delivery methods investigated included hypothermic oxygenated machine perfusion (HOPE), oxygen carriers, two-layer method, venous systemic persufflation, hyperbaric oxygenation, normothermic machine perfusion and sub-normothermic machine perfusion. The COMPARE trial was the only study carried out with the most methodological robustness being a randomised, double blind, controlled, phase III trial that investigated the efficacy of HOPE versus HMP. CONCLUSION A variety of studies reflect the evolution of oxygenation with useful lessons and encouraging outcomes. The first in human studies investigating HOPE and oxygen carriers are most robustly investigated strategies for oxygenation during kidney preservation and are, therefore, the best clinical references.
Collapse
Affiliation(s)
- B Mesnard
- Department of Urology and Transplantation Surgery, University Hospital Center, 1 Place Alexis Ricordeau, 44093, Nantes Cedex 03, France
| | | | - G Karam
- Department of Urology and Transplantation Surgery, University Hospital Center, 1 Place Alexis Ricordeau, 44093, Nantes Cedex 03, France
| | - F Dengu
- Nuffield Department of Surgical Science, Oxford, UK
| | - G Hackim
- Nuffield Department of Surgical Science, Oxford, UK
| | - J Rigaud
- Department of Urology and Transplantation Surgery, University Hospital Center, 1 Place Alexis Ricordeau, 44093, Nantes Cedex 03, France
| | - G Blancho
- Centre de Recherche en Transplantation et Immunologie (ou CRTI), Inserm, Nantes University, Nantes, France
| | - S Drouin
- Department of Urology, Hôpital Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Sorbonne University, 75013, Paris, France
| | - M O Timsit
- Department of Urology and Transplant Surgery, HEGP-Necker, APHP Université Paris Descartes, Paris, France
| | - J Branchereau
- Department of Urology and Transplantation Surgery, University Hospital Center, 1 Place Alexis Ricordeau, 44093, Nantes Cedex 03, France. .,Nuffield Department of Surgical Science, Oxford, UK. .,Centre de Recherche en Transplantation et Immunologie (ou CRTI), Inserm, Nantes University, Nantes, France. .,Institut de Transplantation Urologie Néphrologie (ITUN), Centre Hospitalier Universitaire de Nantes, 44093, Nantes, France.
| |
Collapse
|
24
|
Broudeur L, Loubersac T, Le Normand L, Karam G, Branchereau J, Rigaud J, Perrouin-Verbe MA. New technique of robot-assisted laparoscopic artificial urinary sphincter implantation in female by a posterior approach with intraoperative cystoscopic monitoring. Eur Urol 2021. [DOI: 10.1016/s0302-2838(21)00497-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
25
|
Broudeur L, Loubersac T, Le Normand L, Karam G, Branchereau J, Rigaud J, Perrouin-Verbe MA. New technique of robot-assisted laparoscopic artificial urinary sphincter implantation in female by a posterior approach with intraoperative cystoscopic monitoring. World J Urol 2021; 39:4221-4226. [PMID: 34050814 DOI: 10.1007/s00345-021-03739-w] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/02/2021] [Accepted: 05/18/2021] [Indexed: 11/26/2022] Open
Abstract
PURPOSE To report the early experience of a modified technique of robot-assisted artificial urinary sphincter (AUS) implantation in female, with a posterior approach to the bladder neck and intraoperative real-time cystoscopic monitoring. METHODS Retrospective monocentric study included all consecutive female who underwent a primary robot-assisted AUS implantation between 2017 and 2019. Real-time intraoperative cystoscopic monitoring was carried out to check the correct level of the dissection and to avoid any injury during bladder neck dissection. Perioperative and intraoperative data, functional outcomes and complications were assessed. Continence was defined as 0 to 1 pad per day. RESULTS Twenty-four patients were included, the median age was 66 years, 23/24 (96%) had previous SUI or prolapse surgery. Two conversions to open surgery and 2 modifications of the surgical technique with anterior dissection of the bladder neck were required due to major vesicovaginal adhesions. Overall, 20 patients underwent the robotic posterior approach. Eleven intraoperative complications in 10 patients (50%) occurred, including 7 bladder injuries 4 vaginal injuries, without the need to stop the procedure. The median hospital stay was 3 days (2-7). One AUS was removed at 1 year due to vaginal erosion. At last follow-up (median 26 months (22-36)), 95% of the devices were in place and activated and the continence rate was 84%. CONCLUSIONS Early functional results of robot-assisted AUS implantation with a posterior approach to the bladder neck and intraoperative cystoscopic monitoring are promising despite the high rate of intraoperative complications due to previous surgeries. Further evaluation of this technique is required.
Collapse
Affiliation(s)
- L Broudeur
- Department of Urology, Hôtel Dieu, Nantes University Hospital, 1 Place Alexis Ricordeau, Nantes CEDEX 03, 44093, Nantes, France.
| | - T Loubersac
- Department of Urology, Hôtel Dieu, Nantes University Hospital, 1 Place Alexis Ricordeau, Nantes CEDEX 03, 44093, Nantes, France
| | - L Le Normand
- Department of Urology, Hôtel Dieu, Nantes University Hospital, 1 Place Alexis Ricordeau, Nantes CEDEX 03, 44093, Nantes, France
| | - G Karam
- Department of Urology, Hôtel Dieu, Nantes University Hospital, 1 Place Alexis Ricordeau, Nantes CEDEX 03, 44093, Nantes, France
| | - J Branchereau
- Department of Urology, Hôtel Dieu, Nantes University Hospital, 1 Place Alexis Ricordeau, Nantes CEDEX 03, 44093, Nantes, France
| | - J Rigaud
- Department of Urology, Hôtel Dieu, Nantes University Hospital, 1 Place Alexis Ricordeau, Nantes CEDEX 03, 44093, Nantes, France
| | - M A Perrouin-Verbe
- Department of Urology, Hôtel Dieu, Nantes University Hospital, 1 Place Alexis Ricordeau, Nantes CEDEX 03, 44093, Nantes, France
| |
Collapse
|
26
|
Lepoittevin L, Leon G, Perrouin-Verbe B, Lefort M, Reiss B, Karam G, Rigaud J, Le Normand L, Perrouin-Verbe MA. [External sphincterotomy in neurological patients with detrusor sphincter dyssynergia: Short and mid-term results]. Prog Urol 2021; 32:40-46. [PMID: 33541792 DOI: 10.1016/j.purol.2020.12.009] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/13/2020] [Revised: 12/05/2020] [Accepted: 12/08/2020] [Indexed: 11/24/2022]
Abstract
BACKGROUND To evaluate in the short and mid-term the success of external sphincterotomy (ES) in neurological patients with detrusor sphincter dyssynergia (DSD). METHODS Retrospective, monocentric study, conducted in 51 patients who had a first ES between January 2003 and June 2018, with at least two years of follow-up. The success of ES was defined by maintenance of reflex voiding mode at the end of follow-up. Secondary outcomes were early postoperative complications, rate of revision, functional impact, urodynamic follow-up and upper urinary tract impact. RESULTS The median age was 50.6 years and the median follow-up was 4.6 years. The success rate was 80% (n=41). Ten patients had to change their voiding mode. For 5 patients, it was related to secondary detrusor low contractility. A second ES was required for 39% of patients. At the end of follow-up, there was a significant improvement in Autonomic Dysreflexia (AD) (26 vs 7 patients, P<0.001), urinary tract infections (UTI) (31 vs 15 patients, P<0.001) and a significant decrease in post-voiding residuals (200 vs 50mL, P<0.001). CONCLUSION ES allowed to maintain reflex voiding in 80% of our patients. It significantly improves AD and UTI despite a high rate of re-operation (39%). A long-term follow-up is mandatory in order not to ignore a recurrence of bladder outlet obstruction and/or decrease in detrusor contractility, which may justify a re-operation or an alternative bladder management. LEVEL OF EVIDENCE III.
Collapse
Affiliation(s)
- L Lepoittevin
- Service universitaire de médecine physique et réadaptation neurologique, centre hospitalier universitaire de Nantes, site Saint-Jacques, 85, rue Saint-Jacques, 44093 Nantes, France.
| | - G Leon
- Service de chirurgie urologique, centre hospitalier universitaire de Nantes, site Hôtel Dieu, 1, place Alexis-Ricordeau, 44093 Nantes, France
| | - B Perrouin-Verbe
- Service universitaire de médecine physique et réadaptation neurologique, centre hospitalier universitaire de Nantes, site Saint-Jacques, 85, rue Saint-Jacques, 44093 Nantes, France
| | - M Lefort
- Service universitaire de médecine physique et réadaptation neurologique, centre hospitalier universitaire de Nantes, site Saint-Jacques, 85, rue Saint-Jacques, 44093 Nantes, France
| | - B Reiss
- Service universitaire de médecine physique et réadaptation neurologique, centre hospitalier universitaire de Nantes, site Saint-Jacques, 85, rue Saint-Jacques, 44093 Nantes, France
| | - G Karam
- Service de chirurgie urologique, centre hospitalier universitaire de Nantes, site Hôtel Dieu, 1, place Alexis-Ricordeau, 44093 Nantes, France
| | - J Rigaud
- Service de chirurgie urologique, centre hospitalier universitaire de Nantes, site Hôtel Dieu, 1, place Alexis-Ricordeau, 44093 Nantes, France
| | - L Le Normand
- Service de chirurgie urologique, centre hospitalier universitaire de Nantes, site Hôtel Dieu, 1, place Alexis-Ricordeau, 44093 Nantes, France
| | - M A Perrouin-Verbe
- Service de chirurgie urologique, centre hospitalier universitaire de Nantes, site Hôtel Dieu, 1, place Alexis-Ricordeau, 44093 Nantes, France
| |
Collapse
|
27
|
Fosse A, Karam G, Kerleau C, Perrouin-Verbe, Rigaud J, Baron M, Mesnard B, Hedhli O, Ville S, De Vergie S, Chelghaf I, Loubersac T, Boutin JM, Faivre d'Arcier B, Bruyère F, Cantarovich D, Branchereau J. [Acute renal failure of the donor in encephalic death: A real contraindication to kidney transplantation?]. Prog Urol 2021; 31:519-530. [PMID: 33478867 DOI: 10.1016/j.purol.2020.11.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/04/2020] [Revised: 11/10/2020] [Accepted: 11/12/2020] [Indexed: 11/25/2022]
Abstract
INTRODUCTION The shortage of kidney transplants encourages the expansion of the limits of eligibility criteria for donation. Many donors who are brain dead display acute renal failure at the time of death; is this a real contraindication to harvesting? The aim of this study was to assess kidney graft survival from donors after brain death with confirmed acute renal failure, with or without anuria previous donation. MATERIALS AND METHODS All of the transplants performed in two university hospitals between 2010 and 2017 were analyzed retrospectively. All patients who underwent single kidney transplant from a brain-dead donor with acute renal failure (ARF) were included in this study. ARI was defined here by a decrease over 50 % of glomerular filtration rate (GFR) to a threshold below 45mL/min/1.73 m2 at the time of kidney procurement. Kidney graft survival, incidence of delayed graft function (DGF) and the GFR at 12 months were analyzed. Analysis of kidney transplant survival based on pre-implantation biopsies was additionally done. RESULTS One hundred and sixty four patients were transplanted with a kidney from donor with ARF during the selected period. At the admission in ICU the average GFR was 67,7±19mL/min/1,73m2. At the time of donation, the average age of donors was 56.4±17.7 years, the GFR was 33.7±8.0mL/min/1.73 m2 16 % of donors were anuric. Cold ischemia time (CIT) was 16.8±5.0hours. The average age of recipients was 55.6±14.1 years. 81 % of the cases were primary transplants. Graft function took place within 7.8±9.4 days after transplantation. There were two non-primary functions (PNF). One hundred and fifty two patients (93 %) had a functional graft at 12 months. The mean GFR at 12 months was 46.8±20.1mL/min/1.73 m2 and 122 patients (73 %) had a GFR greater than 30mL/min/1.73 m2. Seventy-one percent of preimplantation biopsies revealed acute tubular necrosis (ATU); no cortical necrosis was observed. Survival of theses grafts was 85 %, comparable to the total population of study (P=0,21) CONCLUSION: The acute renal failure of the brain-dead donor should not alone be systematically a contraindication to harvesting and kidney transplantation.
Collapse
Affiliation(s)
- A Fosse
- Service d'urologie et de transplantations rénales, CHRU de Nantes-Hôtel-Dieu, 1, place Alexis-Ricordeau, 44093 Nantes cedex 1, France.
| | - G Karam
- Service d'urologie et de transplantations rénales, CHRU de Nantes-Hôtel-Dieu, 1, place Alexis-Ricordeau, 44093 Nantes cedex 1, France; Institut de transplantation urologie-néphrologie, 30, boulevard Jean-Monnet, 44093 Nantes, France
| | - C Kerleau
- Institut de transplantation urologie-néphrologie, 30, boulevard Jean-Monnet, 44093 Nantes, France; Centre de recherche en transplantation et immunologie, UMR 1064, Inserm, 30, boulevard Jean-Monnet, 44093 Nantes, France
| | - Perrouin-Verbe
- Institut de transplantation urologie-néphrologie, 30, boulevard Jean-Monnet, 44093 Nantes, France
| | - J Rigaud
- Service d'urologie et de transplantations rénales, CHRU de Nantes-Hôtel-Dieu, 1, place Alexis-Ricordeau, 44093 Nantes cedex 1, France; Institut de transplantation urologie-néphrologie, 30, boulevard Jean-Monnet, 44093 Nantes, France
| | - M Baron
- Service d'urologie, CHU de Rouen, 76031 Rouen cedex 1, France
| | - B Mesnard
- Service d'urologie et de transplantations rénales, CHRU de Nantes-Hôtel-Dieu, 1, place Alexis-Ricordeau, 44093 Nantes cedex 1, France
| | - O Hedhli
- Service d'urologie et de transplantations rénales, CHRU de Nantes-Hôtel-Dieu, 1, place Alexis-Ricordeau, 44093 Nantes cedex 1, France
| | - S Ville
- Institut de transplantation urologie-néphrologie, 30, boulevard Jean-Monnet, 44093 Nantes, France; Centre de recherche en transplantation et immunologie, UMR 1064, Inserm, 30, boulevard Jean-Monnet, 44093 Nantes, France
| | - S De Vergie
- Service d'urologie et de transplantations rénales, CHRU de Nantes-Hôtel-Dieu, 1, place Alexis-Ricordeau, 44093 Nantes cedex 1, France
| | - I Chelghaf
- Service d'urologie et de transplantations rénales, CHRU de Nantes-Hôtel-Dieu, 1, place Alexis-Ricordeau, 44093 Nantes cedex 1, France
| | - T Loubersac
- Service d'urologie et de transplantations rénales, CHRU de Nantes-Hôtel-Dieu, 1, place Alexis-Ricordeau, 44093 Nantes cedex 1, France
| | - J M Boutin
- Service d'urologie, CHRU de Bretonneau, 2, boulevard Tonnellé, 37044 Tours cedex, France
| | - B Faivre d'Arcier
- Service d'urologie, CHRU de Bretonneau, 2, boulevard Tonnellé, 37044 Tours cedex, France
| | - F Bruyère
- Service d'urologie, CHRU de Bretonneau, 2, boulevard Tonnellé, 37044 Tours cedex, France
| | - D Cantarovich
- Institut de transplantation urologie-néphrologie, 30, boulevard Jean-Monnet, 44093 Nantes, France; Centre de recherche en transplantation et immunologie, UMR 1064, Inserm, 30, boulevard Jean-Monnet, 44093 Nantes, France
| | - J Branchereau
- Service d'urologie et de transplantations rénales, CHRU de Nantes-Hôtel-Dieu, 1, place Alexis-Ricordeau, 44093 Nantes cedex 1, France; Institut de transplantation urologie-néphrologie, 30, boulevard Jean-Monnet, 44093 Nantes, France; Centre de recherche en transplantation et immunologie, UMR 1064, Inserm, 30, boulevard Jean-Monnet, 44093 Nantes, France; Nuffield department of surgical sciences, Oxford university, Oxford, UK
| |
Collapse
|
28
|
Poujade L, Branchereau J, Rigaud J, Perrouin-Verbe MA. Ileal ureter replacement: Early morbidity and long-term results. Prog Urol 2020; 31:357-367. [PMID: 33189554 DOI: 10.1016/j.purol.2020.10.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/20/2020] [Revised: 09/25/2020] [Accepted: 10/07/2020] [Indexed: 11/17/2022]
Abstract
INTRODUCTION Ileal ureter is a technique that consists of replacing the ureter by a segment of ileum to treat a long ureteric lesion or a lesion involving the lumbar ureter. The primary objective of our study was to assess the early perioperative morbidity of ileal ureter according to the Clavien-Dindo classification. The secondary objectives were to assess the morbidity and the medium- and long-term outcome of renal function. MATERIALS AND METHODS Single-centre retrospective study, collecting data from patients operated between February 2005 and October 2019. All patients who underwent ileal ureter replacement surgery in our unit were included in this analysis. The ureteric defect was longer than five centimetres and involved the pelvic and/or iliac and/or lumbar ureter. All ileal ureter replacements were performed by open surgery using isoperistaltic ileal grafts. RESULTS Twenty-one patients (11 women and 10 men) underwent total or subtotal, unilateral or bilateral ileal ureter replacement, corresponding to 25 kidneys. The grade III early postoperative complication rate was 9.5% (two cases) mainly consisting of bleeding. No grade IV or V complications were observed. With a mean follow-up of 85 months, long-term morbidity essentially consisted of infectious complications. No patients developed anastomotic strictures. Mean serum creatinine was 116.3μmol/L preoperatively, 105.6μmol/L one month postoperatively and 112.2μmol/L at last follow-up. Renal function was generally preserved or even improved, except for patients with preoperative renal failure. CONCLUSION Ileal ureter replacement is a surgical alternative associated with low morbidity and satisfactory long-term functional results. LEVEL OF EVIDENCE 3.
Collapse
Affiliation(s)
- L Poujade
- Service d'urologie, CHU de Nantes, 1, place Alexis-Ricordeau, 44093 Nantes cedex 1, France.
| | - J Branchereau
- Service d'urologie, CHU de Nantes, 1, place Alexis-Ricordeau, 44093 Nantes cedex 1, France
| | - J Rigaud
- Service d'urologie, CHU de Nantes, 1, place Alexis-Ricordeau, 44093 Nantes cedex 1, France
| | - M-A Perrouin-Verbe
- Service d'urologie, CHU de Nantes, 1, place Alexis-Ricordeau, 44093 Nantes cedex 1, France
| |
Collapse
|
29
|
Loubersac T, Branchereau J, Rigaud J, Le Normand L, Perrouin-verbe M. Cystostomie continente de type mitrofanoff associée à une entéro-cystoplastie d’agrandissement par voie cœlioscopique robot-assistée. Prog Urol 2020. [DOI: 10.1016/j.purol.2020.08.020] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
30
|
Mesnard B, Leroy M, Hunter J, Kervella D, Timsit M, Badet L, Glemain P, Prudhomme T, Dantal J, De Vergie S, Bouchot O, Rigaud J, Karam G, Giral M, Branchereau J. Transplantations rénales à partir de donneurs décédés par arrêt circulatoire contrôlé M3 et non contrôlé M2 : un impact sur les complications urinaires ? Étude multicentrique de 317 transplantations DDAC. Prog Urol 2020. [DOI: 10.1016/j.purol.2020.07.049] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
31
|
Graveleau A, Pere M, Kerleau C, Morelon E, Badet L, Ladriere M, Hubert J, Legendre C, Mejean A, Timsit M, Sicard A, Albano L, Perrouin-Verbe M, De Vergie S, Bouchot O, Glemain P, Blancho G, Rigaud J, Karam G, Branchereau J. Identification des facteurs de risque d’échec des troisièmes transplantations rénales, analyse multicentrique de 269 greffes. Prog Urol 2020. [DOI: 10.1016/j.purol.2020.07.050] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
32
|
Loubersac T, Glémain P, Perrouin-Verbe M, Rigaud J, Chelghaf I, Bouteille C, Paret F, Delforge X, Camby C, Guinot A, De Napoli S, Faraj S, Leclair M. Efficacité et faisabilité de la mini néphrolithotomie percutanée < 15 F (miniNLPC) dans la prise en charge des calculs rénaux complexes en urologie pédiatrique : expérience initiale d’un centre tertiaire d’urologie pédiatrique français. Prog Urol 2020. [DOI: 10.1016/j.purol.2020.07.025] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
33
|
Allenet C, De Vergie S, Perrouin-verbe M, Branchereau J, Rigaud J. Curage latéro-aortique laparoscopique robot-assistée pour récidive ganglionnaire lombo-aortique d’une tumeur testiculaire gauche. Prog Urol 2020. [DOI: 10.1016/j.purol.2020.08.048] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
34
|
Loubersac T, Perrouin-Verbe M, Rigaud J, Glémain P. Fermeture d’une fistule urétéro-vésico-vaginale avec réimplantation urétéro-vésicale sous coelioscopie robot-assistée. Prog Urol 2020. [DOI: 10.1016/j.purol.2020.08.019] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
35
|
Jeanne-Julien A, Cantarovich D, Guillot-Gueguen C, Blancho G, de Vergie S, Chelghaf I, Bouchot O, Perrouin-Verbe M, Glemain P, Rigaud J, Karam G, Branchereau J. Transplantation de pancréas isolé, toujours une réelle alternative au pancréas artificiel et à la transplantation d’îlots ? Résultats d’une série de 45 patients. Prog Urol 2020. [DOI: 10.1016/j.purol.2020.07.055] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
36
|
Batard T, Mesnard B, Rigaud J, Branchereau J, Glemain P, Karam G, Bouchot O, Perrouin Verbe B, Le Normand L, Perrouin Verbe M. Long-term functional outcomes and complications of augmentation enterocystoplasty in adult patients with neurogenic bladder: A single-center experience in a multidisciplinary team. EUR UROL SUPPL 2020. [DOI: 10.1016/s2666-1683(20)33041-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
|
37
|
Loubersac T, Branchereau J, Bouchot O, Rigaud J, Glemain P, Karam G, Le Normand L, Perrouin-Verbe MA. Robot-assisted laparoscopic continent cutaneous urinary diversion (Mitrofanoff and Yang-Monti conduits) in a consecutive series of 8 adult patients. Surgical technique and initial outcomes: A Mitrofanoff with bladder augmentation procedure. EUR UROL SUPPL 2020. [DOI: 10.1016/s2666-1683(20)34240-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
38
|
Paret F, Leclair M, Branchereau J, Karam G, Rigaud J, Lenormand L, Perrouin Verbe M. Long term results of artificial urinary sphincter implantation for stress urinary incontinence in children: A monocentric retrospective study. EUR UROL SUPPL 2020. [DOI: 10.1016/s2666-1683(20)33994-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
39
|
Mesnard B, Leroy M, Karam G, Neri F, Glemain P, Perrouin-Verbe M, De Vergie S, Bouchot O, Rigaud J, Cantarovich D, Blancho G, Giral M, Branchereau J. Kidney transplantation from extended-criteria donors: An increased risk of ureteral and urinary complications? Study from 10279 patients. EUR UROL SUPPL 2020. [DOI: 10.1016/s2666-1683(20)33659-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
|
40
|
Grevez T, Lavalle E, Broudeur L, Karam G, Rigaud J, Buschler M, Bruyère F, Branchereau J. Intérêt de l’héparinothérapie peropératoire au cours des transplantations rénales réalisées avec un rein prélevé sur donneur vivant, étude comparative multicentrique. Prog Urol 2019. [DOI: 10.1016/j.purol.2019.08.100] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
41
|
Allenet C, De Vergie S, Rigaud J. Adénomectomie prostatique laparoscopique robot-assistée selon la technique de MILLIN. Prog Urol 2019. [DOI: 10.1016/j.purol.2019.08.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
42
|
Mesnard B, Leroy M, Karama G, Glemain P, Perrouin-Verbe M, De Vergie S, Bouchot O, Rigaud J, Giral M, Branchereau J. Transplantation rénale avec donneurs à critères élargis : une augmentation du risque de complications urétérales ? Étude à partir de 10 279 patients. Prog Urol 2019. [DOI: 10.1016/j.purol.2019.08.102] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
43
|
Chelly S, Drillaud N, Fouassier M, De Vergie S, Perrouin-Verbe M, Rigaud J, Trossaert M, Branchereau J. Évaluation de la morbidité dans le cancer de la prostate localisé des patients porteurs d’une hémophile de type A, de type B ou d’une maladie de von Willebrand. Prog Urol 2019. [DOI: 10.1016/j.purol.2019.08.253] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
44
|
Loubersac T, Hétet JF, Colls P, Rigaud J, Supiot S. Radiothérapie de rattrapage des cancers de prostate après échec de la cryothérapie. Cancer Radiother 2019. [DOI: 10.1016/j.canrad.2019.07.078] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
45
|
Nédélec M, Glémain P, Rigaud J, Karam G, Thuret R, Badet L, Kleinclauss F, Timsit MO, Branchereau J. [Renal transplantation on vascular prosthesis]. Prog Urol 2019; 29:603-611. [PMID: 31447181 DOI: 10.1016/j.purol.2019.06.005] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/10/2019] [Revised: 05/29/2019] [Accepted: 06/13/2019] [Indexed: 10/26/2022]
Abstract
INTRODUCTION In front of a very calcified aortoiliac axis, renal transplantation with implantation of the artery on vascular prosthesis can be proposed. This rare intervention is considered difficult and morbid. The main objective of this work was to evaluate the overall and specific survival of the transplant in this situation. The secondary objective was the study of the complications and the evolution of the transplant's renal function. MATERIAL AND METHODS From a multicenter retrospective data collection of the DIVAT cohort (6 centers) added with data from 4 other transplant centers, we studied transplants with prosthetic arterial anastomosis. RESULTS Thirty four patients was included. The median duration of follow-up was 2.5 years. 4 patients died in the month following transplantation, 16 were hemodialysis and 9 were transfused. The median survival of the transplant was 212 days. Functional arrests of the transplant were mostly associated with nephrological degradation and return to dialysis (about 80%) while 10% were related to a death of the recipient directly attributable to renal transplantation. The surgical complications of the transplantation were marked by one arterial stenosis, one fistula and 4 urinary stenoses. CONCLUSION Thus, renal transplantation with arterial anastomosis on vascular prosthesis, on selected patients, offers an alternative to dialysis. A national compendium of transplanted patients on vascular prosthesis would allow a long-term follow-up of transplant's survival and define selection criteria prior to this kind of surgery. LEVEL OF EVIDENCE 3.
Collapse
Affiliation(s)
- M Nédélec
- Institut de Transplantation Urologie Néphrologie (ITUN), CHU Nantes, 44093 Nantes, France
| | - P Glémain
- Institut de Transplantation Urologie Néphrologie (ITUN), CHU Nantes, 44093 Nantes, France
| | - J Rigaud
- Institut de Transplantation Urologie Néphrologie (ITUN), CHU Nantes, 44093 Nantes, France
| | - G Karam
- Institut de Transplantation Urologie Néphrologie (ITUN), CHU Nantes, 44093 Nantes, France; Comité de transplantation et d'insuffisance rénale chronique (CTIRC), 75017 Paris, France
| | - R Thuret
- Service d'urologie, CHU de Montpellier, 371, avenue du Doyen-Gaston Giraud, 34295 Montpellier cedex 5, France; Comité de transplantation et d'insuffisance rénale chronique (CTIRC), 75017 Paris, France
| | - L Badet
- Service d'urologie, hôpital Edouard-Herriot, hospices civils de Lyon, 69437 Lyon cedex 03, France; Comité de transplantation et d'insuffisance rénale chronique (CTIRC), 75017 Paris, France
| | - F Kleinclauss
- Service d'urologie, CHRU de Besançon, 25030 Besançon cedex, France; Comité de transplantation et d'insuffisance rénale chronique (CTIRC), 75017 Paris, France
| | - M O Timsit
- Service d'urologie, hôpital Européen Georges-Pompidou (HEGP), AP-HP, 75015 Paris, France; Comité de transplantation et d'insuffisance rénale chronique (CTIRC), 75017 Paris, France
| | - J Branchereau
- Institut de Transplantation Urologie Néphrologie (ITUN), CHU Nantes, 44093 Nantes, France; Centre de Recherche en Transplantation et Immunologie UMR 1064, Inserm, Université de Nantes, 44093 Nantes, France; Comité de transplantation et d'insuffisance rénale chronique (CTIRC), 75017 Paris, France.
| |
Collapse
|
46
|
Broudeur L, Karam G, Chelghaf I, De Vergie S, Rigaud J, Perrouin Verbe MA, Branchereau J. Feasibility and safety of laparoscopic living donor nephrectomy in case of right kidney and multiple-renal artery kidney: a systematic review of the literature. World J Urol 2019; 38:919-927. [PMID: 31129713 DOI: 10.1007/s00345-019-02821-8] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/03/2018] [Accepted: 05/21/2019] [Indexed: 01/27/2023] Open
Abstract
PURPOSE To access the current status of the security and feasibility of right kidney (RK) and multiple-renal artery (MRA) laparoscopic living donor nephrectomy (LLDN) which are more challenging compared to left kidney (LK) and single renal artery (SRA) because of a shorter renal vein and more complex vascular anatomy. METHODS We did a systematic review of the literature according to the PRISMA recommendations, reporting RK or MRA donor nephrectomy performed with a laparoscopic technique compared to LK or SRA kidney LLDN. The identified and analyzed primary outcomes of interest were operating time (OT), warm ischemia time (WIT), rate of conversion and transfusion, donor length of stay (LOS), delayed graft function (DGF) and rate of graft loss (GL). RESULTS 16 comparative studies (1397 cases) of RK-LLDN and 12 comparative studies including 15 series (993 cases) of MRA-LLDN were selected. For RK-LLDN review, conversion rate was 0.8% and blood transfusion rate 0.2%, only one case of graft venous thrombosis was reported, OT was shorter in four studies and there was no any difference of DGF and GL rate compared to LK-LLDN. For MRA-LLDN review, conversion rate was 1.3% and blood transfusion rate 1.1%, OT and WIT were longer compared to SRA-LLDN, there were more ureteral complications in two studies, and no difference in terms of vascular complications and graft loss rate. CONCLUSION RK-LLDN and MRA-LLDN would be similar to LK-LLDN and SRA-LLDN in terms of feasibility and safety for the donor as well as graft function results for RK-LLDN.
Collapse
Affiliation(s)
- L Broudeur
- Department of Urology and Transplantation Surgery, University Hospital Center, 1 Place Alexis Ricordeau, 44093, Nantes Cedex 03, France
| | - G Karam
- Department of Urology and Transplantation Surgery, University Hospital Center, 1 Place Alexis Ricordeau, 44093, Nantes Cedex 03, France
| | - I Chelghaf
- Department of Urology and Transplantation Surgery, University Hospital Center, 1 Place Alexis Ricordeau, 44093, Nantes Cedex 03, France
| | - S De Vergie
- Department of Urology and Transplantation Surgery, University Hospital Center, 1 Place Alexis Ricordeau, 44093, Nantes Cedex 03, France
| | - J Rigaud
- Department of Urology and Transplantation Surgery, University Hospital Center, 1 Place Alexis Ricordeau, 44093, Nantes Cedex 03, France
| | - M A Perrouin Verbe
- Department of Urology and Transplantation Surgery, University Hospital Center, 1 Place Alexis Ricordeau, 44093, Nantes Cedex 03, France
| | - Julien Branchereau
- Department of Urology and Transplantation Surgery, University Hospital Center, 1 Place Alexis Ricordeau, 44093, Nantes Cedex 03, France. .,Centre de Recherche en Transplantation et Immunologie (ou CRTI), Inserm, Nantes University, Nantes, France. .,Institut de Transplantation Urologie Néphrologie (ou ITUN), CHU Nantes, Nantes, France.
| |
Collapse
|
47
|
Ricard H, Léon G, Le Normand L, Rigaud J, Levesque A, Branchereau J, Bouchot O, Perrouin-Verbe M. Résultats fonctionnels à moyen terme et complications après l’implantation de ballonnets pro-act® pour incontinence urinaire d’effort chez l’homme après prostatectomie radicale. Prog Urol 2018. [DOI: 10.1016/j.purol.2018.07.060] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
48
|
Baron M, Marie-Aimée P, Hedli O, Le Normand L, Levesque A, Rigaud J. Gestion de la récidive d’incontinence urinaire après ablation de bandelette sous-urétrale pour douleur pelvienne ou périnéale. Prog Urol 2018. [DOI: 10.1016/j.purol.2018.07.059] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
49
|
Batard T, Karam G, Glemain P, Le Normand L, Perrouin-Verbe M, Nedellec M, Bouchot O, Lefevre M, De Vergie S, Martin-Lefevre L, Dantal J, Rigaud J, Branchereau J. Transplantations rénale à partir de DDACM3, presque aussi bien que le donneur vivant ! Prog Urol 2018. [DOI: 10.1016/j.purol.2018.07.040] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
50
|
Wagner L, Douvier S, Ruffion A, Saussine C, Soustelle L, Rigaud J, Meurette G, Phé V, Vidart A, Manunta A, Vincens E, Dorez M, Cayrac M, Hoepffner J, Costa P, Droupy S. Essai randomisé, ouvert, multicentrique comparant le taux de complications de la promontofixation (PF) laparoscopique robot-assistée à la promontofixation laparoscopique classique pour le traitement des prolapsus pelviens (PP). Prog Urol 2018. [DOI: 10.1016/j.purol.2018.07.061] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|